Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-10-28 TARNOW MICHAEL M Director Exercise or conversion +5,144 $3.76 $19K 80,001
2020-10-28 TARNOW MICHAEL M Director Gift −10,288 69,713
2020-10-28 TARNOW MICHAEL M Director Exercise or conversion · Stock Option (Right to Buy) −5,144 0
2020-10-28 TARNOW MICHAEL M Director Exercise or conversion · Stock Option (Right to Buy) −5,144 0
2020-10-28 PATOU GARY Director Exercise or conversion +2,057 $3.76 $8K 23,573
2020-10-28 PATOU GARY Director Exercise or conversion · Stock Option (Right to Buy) −2,057 0
2020-08-20 PIMSTONE SIMON N. CEO Other disposition −45,000 210,186
2020-08-17 Von Seggern Christopher Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-06-09 TARNOW MICHAEL M Director Exercise or conversion +5,144 $3.52 $18K 69,713
2020-06-09 TARNOW MICHAEL M Director Exercise or conversion · Stock Option (Right to Buy) −5,144 0
2020-06-01 ROBIN SHERRINGTON EVP, Strategy & Innovation Exercise or conversion +8,230 $3.56 $29K 18,426
2020-06-01 ROBIN SHERRINGTON EVP, Strategy & Innovation Shares withheld for taxes −1,630 $13.70 $22K 16,796
2020-06-01 ROBIN SHERRINGTON EVP, Strategy & Innovation Exercise or conversion · Stock Option (Right to Buy) −8,230 0
2020-06-01 PATOU GARY Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 TARNOW MICHAEL M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 Svoronos Dawn Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 Hayden Michael R Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 GANNON STEVEN Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 Desjardins Clarissa Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 AZAB MOHAMMAD Director Grant or award · Stock Option (Right to Buy) +10,000 10,000

Page 22 of 27 · 536 trades